Pfizer (PFE) Director Cyrus Taraporevala Receives 1,308-Unit Award

What Happened

• Cyrus Taraporevala, a director of Pfizer Inc., was granted 1,307.987 units representing phantom shares as a deferred director compensation award on September 25, 2026. The units are recorded at $28.67 per unit for a total value of $37,500. This was an award (derivative grant), not an open-market purchase or sale.

Key Details

• Transaction date and type: 2026-09-25 — Award/Grant (code A)
• Quantity and valuation: 1,307.987 units at $28.67 per unit = $37,500
• Shares owned after transaction: Not specified in the filing
• Footnotes: F1 — each unit equals one phantom share; F2 — units are deferred director compensation (including dividend equivalents) settled in cash or common stock at the director’s election after retirement from the board
• Timeliness: Filed 2026-09-29 (meets the Form 4 reporting deadline)

Context

• This was a derivative compensation grant (phantom/share units) for director pay, not a market purchase or sale; such awards are routine compensation and do not by themselves indicate the insider’s view on the stock. The units may convert to cash or actual shares later per the director’s election after leaving the board.